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Background: There is no consensus in the literature on the inﬂuence of gender on the
correlations between coronary artery calciﬁcation (CAC) with aortic root calciﬁcation
(ARC) and pericardial fat volume (PFV).
Objective: To investigate the impact of gender on the correlations between PFV, CAC and ARC
in Iraqi patients with suspected coronary artery disease (CAD) assessed by multi-detector CT
(MDCT).
Methods: One hundred and thirty consecutive Iraqi patients with intermediate pretest
probability of ischemic heart disease who underwent MDCT examination for assessment
of CAD were recruited between January and December 2014. Of these, 111 patients were
found to be eligible and were enrolled in the study. Patients were divided into a male group
(n = 54) and a female group (n = 57).
Results: In male patients, PFV showed no signiﬁcant correlation with CAC and ARC. CAC
showed a signiﬁcant correlation with ARC (r = 0.392, P = 0.003). The correlation between CAC
and ARC persisted even after adjustment for PFV, age and cardiac risk factors (P = 0.01,
CI = 0.067–0.492). In female patients, PFV showed a signiﬁcant correlation with CAC
(r = 0.413, P = 0.001) and this correlation persisted even after multivariate regression adjust-
ment for ARC, age and cardiac risk factors (P = 0.016, CI = 0.067–0.612) while there was no
signiﬁcant correlation between PFV and ARC. ARC showed no signiﬁcant correlation with
CAC and PFV. ARC showed a signiﬁcant association with male gender (P = 0.04) while there
was no signiﬁcant difference in PFV and CAC between the two groups of study.
Conclusion: PFV was signiﬁcantly associated with CAC in female patients while ARC showed
a signiﬁcant association with CAC in male patients.
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Gender disparity plays an important role in cardiovascular
disease prevalence and burden with signiﬁcant gender related
differences reported in cardiovascular clinical presentation
mortality, morbidity and risk factors proﬁles [1].
Coronary artery calciﬁcation (CAC) is a reported imaging
marker of subclinical atherosclerosis and has incremental
prognostic values beyond those of traditional cardiac risk
scores for cardiovascular disease (CVD) prognosis and it may
help in reclassiﬁcation of patients at increased risk [2,3].
Pericardial fat is an adipose tissue surrounding the heart,
with anatomic proximity to the epicardial coronary arteries. In
recent years, pericardial fat volume (PFV) has been proposed as
an imaging biomarker of increased cardiovascular risk [4,5].
To the best of the authors' knowledge, there is little
information regarding the association between aortic root
calciﬁcation (ARC) and coronary atherosclerosis markers and
calciﬁcation, because the evaluation of the aortic root or
thoracic aorta calciﬁcation is not a standard part of the routine
cardiovascular workup.
The main aim of this study was to investigate the impact of
gender disparity on the correlations of PFV, CAC and ARC in
patients with intermediate test probability of coronary artery
disease (CAD) assessed by multi-detector CT (MDCT).
Materials and methods
This cross-sectional study was carried out at the Cardiology
Center at Al-Sader Teaching Hospital. Informed consent was
obtained from all individual participants included in the study.
The study was approved by our institution. One hundred and
thirty consecutive Iraqi patients with intermediate pretest
probability of ischemic heart disease based on their age, sex
and cardiac symptoms and who underwent 64-slice MDCT
angiography for assessment of CAD were recruited between
January and December 2014. Of these, 111 patients were found
to be eligible and were enrolled in the study.
Nineteen patients were excluded because of a poor
examination technique or motion artifact (n = 8), aortic root
anomalies or dissection (n = 2), difﬁculty in accurate pericar-
dial fat volume calculation or segmentation of fat (n = 6), or
data were missing (n = 3).
For analytical purposes, patients were divided into two
groups according to their gender: male group [n = 54 (49%)] and
female group [n = 57(51%)].
Using standard physician-based questionnaires, a history
of conventional cardiac risk factors for CAD was obtained from
each patient at the time of coronary MDCT angiography
examination including a positive family history of premature
CAD (occurring before the age of 55 years in men and before 65
years in women), current smoking history (more than 10
cigarettes per day in the last year), a history of hypertension or
use of anti-hypertension medications, hyperlipidemia that
was deﬁned as total cholesterol ≥200 mg/dl or triglyceride
levels ≥150 mg/dl or use of lipid lowering drugs, a history of
diabetes mellitus or use of insulin or diabetic lowering drugs
and obesity with a body mass index ≥30. Patients with two ormore cardiac risk factors were considered to have multiple risk
factors.
CT scan protocol
CT coronary angiography was performed with a 64-slice
scanner (Aquilon 64, v. 4.51 ER 010; Toshiba Medical Systems,
Tochigi, Japan). Before multi-slice CT angiography was
performed, a non-contrast CT was acquired to measure the
calcium score according to the Agatston for total heart calcium
(summed across all lesions identiﬁed within coronary arteries)
using a sequence scan with a slice thickness of 3 mm [6].
Coronary calciﬁcation area was deﬁned as at least three
contiguous voxels with a CT density >130 Hounsﬁeld units.
When the patient's heart rate was more than 65 bpm, a b-
blocker (metoprolol; 20–60 mg orally) was administered before
the scan. A bolus of 80 ml contrast medium (Omnipaque;
350 mg/ml iodine) was injected intravenously at a rate 5 ml/s,
followed by 30 ml of normal saline. The scan was obtained
from the aortic arch to the level of the diaphragm during a
single breath hold. Using retrospective ECG-gating and ECG-
dependent tube current modulation, the following parameters
were performed: collimation, width 32.5 cm  32.5 cm; slice
thickness 0.5 mm; rotation time 0.35 s; tube voltage 120 kV;
maximum effective tube current 890 mA; and table feed
0.3 mm/rotation at 75% of R–R cardiac cycle. Examination
time took 10 s. CT images were reconstructed using a smooth
kernel (B25f) with a slice thickness of 0.5 mm (increment of
0.3 mm). CT data sets were transferred to a dedicated
workstation (Vitrea 2 Workstation; Vital Image, Plymouth,
MN, USA) for image analysis.
The aortic root was deﬁned as the part of the aorta lying
within 3 cm from the caudal aspect of the aortic annulus
containing sinuses of Valsalva and the sinotubular junction.
The total calcium score of the aortic root was calculated using
Agatston method according to this deﬁnition. Areas in the
aortic root with an attenuation >130 Hounsﬁeld units and an
area >1 mm2were considered to be calciﬁed lesions. All MDCT
images were assessed by two independent radiologists with
more than 5 years' experience in coronary MDCT angiography
interpretation.
PFV was deﬁned as any fatty tissue located within the
pericardial sac and measured three-dimensionally with the
contrast-enhanced phase. PFV was measured three-dimen-
sionally with the contrast-enhanced phase. The layer of the
pericardium was manually traced and a three-dimensional
image of the heart was constructed. Then the PFV was
quantiﬁed by calculating the total volume of the tissue whose
CT density ranged from 250 to 20 HU within the pericardi-
um by using three D workstation statistical analysis.
Statistical analysis
Data are presented as mean  standard deviation or as
numbers with percentages, as appropriate. Categorical data
are expressed as frequencies and group comparisons were
performed using Pearson's chi-square test. Continuous vari-
ables are presented as mean  standard deviation and were
compared using the Student's t-test or analysis of variance, as
Fig. 1 – A significant correlation was observed between ARC
and CAC in male patients.
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examined using Pearson's correlation analysis. Multiple
logistic regression was used to analyze the correlations of
CAC with PFV and ARC. A P-value of less than 0.05 was
considered statistically signiﬁcant. SPSS ver. 13.0 (SPSS Inc.,
Chicago, IL, USA) was used for the statistical analysis.
Results
Male group
Composed of 54 (49%) patients, age 54  10 years. PFV mean
and median were 119.8  79 cm3 and 107 cm3 respectively and
ranged from 10 to 375 cm3. ARC (calcium score above zero)
prevalence was 30%. CAC (calcium score above zero) preva-
lence was 39%. Patient characteristics are summarized in
Table 1.
PFV showed no signiﬁcant correlation with CAC, ARC and
age of patients (P > 0.05). CAC showed a signiﬁcant correlation
with ARC (r = 0.392, P = 0.003; Fig. 1) and patient's age (r = 0.363,
P = 0.007). The correlation between CAC and ARC persisted
even after adjustment for PFV, age and cardiac risk factors
(P = 0.01, CI = 0.067–0.492) while the correlation between age
and CAC becomes non-signiﬁcant after being adjusted to
cardiac risk factors, ARC and PFV (P = 0.158, CI = 1.09–6.50).
ARC showed a signiﬁcant association with patient's age
(r = 0.303, P = 0.02) but this correlation attenuated and became
non-signiﬁcant after multivariate regression adjustment for
cardiac risk factors, CAC and PFV (P = 0.146, CI = 1.28 to 8.38).
Female group
Composed of 57 (51%) patients (age 54.7  9 years). PFV mean
and median were 102.2  74 cm3 and 78 cm3 respectively and
ranged from 7 to 367 cm3. ARC (calcium score above zero)
prevalence was 28%. CAC (calcium score above zero) preva-
lence was 30%. PFV showed a signiﬁcant correlation with CAC
(r = 0.413, P = 0.001; Fig. 2) and this correlation persisted even
after multivariate regression adjustment for ARC, age andTable 1 – Patients' characteristics.
Parameter Male
n = 54
Female
n = 57
P value
Age 54  10 years 54.7  9.6 years 0.7
Cardiac risk factors
Hypertension 17 (31%) 34 (60%) 0.003
Smoking 13 (24%) 16 (28%) 0.6
Hyperlipidemia 8 (15%) 11(19%) 0.5
Diabetes 6 (11%) 2 (3.5) 0.1
Family history 5 (9%) 6 (10%) 0.8
Obesity 9 (17%) 19 (33%) 0.04
Multiple 14 (26%) 17 (30%) 0.6
CAC
Mean 80  146 38  91 0.07
ARC
Mean 65.5  178 14.8  48 0.04
PFV
Mean 119  79 cm3 102  74 cm3 0.2cardiac risk factors (P = 0.016, CI = 0.067–0.612) while there was
no signiﬁcant correlation between PFV with ARC and age of
patients (P > 0.05). ARC showed no signiﬁcant correlation with
CAC and PFV (P > 0.05).
Regarding the distribution of cardiac risk factors among
male and female groups, hypertension and obesity were more
prevalent in females compared to males (P = 0.003 and 0.04
respectively).
Comparison between male and female groups regarding
CAC, PFV and ARC difference showed a signiﬁcant association
of ARC with male gender (P = 0.04) while there was no
signiﬁcant difference in PFV and CAC between the two groups
of study.Fig. 2 – A significant correlation was observed between PFV
and CAC in female patients.
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In our study, PFV was signiﬁcantly correlated with CAC in
female patients while ARC showed a signiﬁcant correlation
with CAC in male patients.
There was no signiﬁcant gender related difference in the
prevalence of CAC and PFV except for ARC which was more
prevalent in male patients.
The gender gap in cardiovascular disease clinical presen-
tation, risk factors proﬁles, morbidity and mortality has been
reported with multiple potential factors that could be
attributed for this gap [1,7].
According to the results of autopsy in 83 patients who
died from acute coronary syndrome, gender gap appears to
be related to factors peculiar to women although both male
and female patients present the same overall plaque burden
[7].
So, it is of paramount importance to search for a sensitive
imaging biomarker of cardiovascular atherosclerosis risk in
both male and female patients.
There is no consensus in the literature on the inﬂuence of
gender on the pericardial fat deposits.
However, Rosito et al. suggest that cardiac fat is more
associated with risk factors in females than in males [8].
Gender related differences have been reported in the
pathophysiology of major risk factors, including hypertension,
obesity and vascular atherosclerosis. Framingham Heart Study
reported that visceral adipose tissue was signiﬁcantly associ-
ated with blood pressure, impaired fasting glucose and
metabolic syndrome and these relations between visceral
adipose and risk factors were consistently stronger in women
than in men [9].
This might help explain the higher prevalence of hyper-
tension and obesity in female patients compared to the male
patients in our study.
A more profound fat redistribution has been reported to
occur in female than in male rats particularly with increasing
age and this might help explain the potential role of adipose
tissue in coronary atherosclerosis in post-menopausal women
[10].
Interestingly, cardiac fat amount measured by transtho-
racic echocardiography was the only independent inverse
predictor of coronary ﬂow reserve, as opposed to conventional
risk factors for atherosclerosis in women complaining of chest
pain suggesting the importance of cardiac fat as an easy
diagnostic marker for risk stratiﬁcation of women with chest
pain [11].
It has been reported that body mass index (BMI) and waist
circumference have limited sensitivity and speciﬁcity in
correlation with cardiovascular risk and may not be represen-
tative of visceral adipose burden [12,13].
In the last decade, increased pericardial fat thickness
measured by using echocardiography or PFV by using CT/
MRI correlates well with visceral adiposity and metabolic
syndrome, and hence is associated with CAD risk and extent
[13].
There is a signiﬁcant gender difference in calciﬁcation
pattern and coronary heart disease presentation and males
younger than 60 years tended to have a unique pattern ofcoronary calciﬁcation and earlier presentation compared to
females of similar age [14].
Interestingly, it has been reported that females have a
greater microvascular and endothelial dysfunction relative to
males and pericardial fat is associated with early endothelial
dysfunction that may precede coronary calciﬁcation and the
development of mature atherosclerotic changes whereas the
coronary calcium score could represent a stable phase of
atherosclerosis [4].
These gender related differences in CAC pattern and
endothelial dysfunction could be the explanation for the lack
of association between CAC and PFV in male patients.
The potential role of ARC over measured conventional risk
factors and CAC in identifying asymptomatic patients before
clinical cardiac events remains to be determined as aortic
calciﬁcation may presage the development of symptomatic
coronary artery disease particularly in patients with hyperlip-
idemia [2,15].
Thoracic aortic calcium score has been shown to be
independently associated with age ≥65 years and male sex,
and abdominal aortic calcium score was shown to be
independently associated with age ≥65 years in 315 patients
assessed by positron-emission tomography/computed tomog-
raphy [16].
In addition, Takasu et al. found a higher prevalence of
ascending aortic calciﬁcation in male patients aged 55 years
and older [17].
Our previous study reported that ARC signiﬁcantly corre-
lated with CAC, coronary calciﬁed plaques and number of
coronary stenotic vessels measured using the volumetric and
Agatston scoring methods [2].
There were several limitations in this study. First, the study
was a single center investigation, and the population was not
randomly selected, as it involved only patients with intermedi-
ate pretest probability of ischemic heart disease based on
physician referral. There is, therefore, the possibility of selection
bias. Second, our algorithm for quantifying PFV was not
completely automatic and still required user interaction. Third,
a causal relationship between ARC, CAC and PFV cannot be
established because of the cross-sectional nature of our study.
Further studies using increased population sizes and with
follow-ups are needed to investigate the role of and gender
related difference of ARC and PFV as an imaging marker with
prognostic signiﬁcance in identifying patients with advanced
coronary disease, and also to report on the effect of intensive
therapeutic strategies on PFV and ARC.
Conclusion
A signiﬁcant impact of gender disparity on the correlations
between CAC with ARC and PFV was reported in this study.
The ﬁndings highlight the importance of PFV in coronary
atherosclerosis development in female gender and the
signiﬁcant correlation of ARC with coronary atherosclerosis
in male gender.
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